Lactylation-driven FTO targets CDK2 to aggravate microvascular anomalies in diabetic retinopathy.
Chen X, Wang Y, Wang JN, Zhang YC, Zhang YR, Sun RX, Qin B, Dai YX, Zhu HJ, Zhao JX, Zhang WW, Ji JD, Yuan ST, Shen QD, Liu QH.
Chen X, et al. Among authors: yuan st.
EMBO Mol Med. 2024 Feb;16(2):294-318. doi: 10.1038/s44321-024-00025-1. Epub 2024 Jan 31.
EMBO Mol Med. 2024.
PMID: 38297099
Free PMC article.